SCHEMBL1379346

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL1376532	0.97	KMT2A (0.43)	MEN1KMT2APOLB
	SCHEMBL1379356	0.94	ATM (0.39)	MEN1KMT2APOLBALDH1A1LMNA
	SCHEMBL2920939	0.87	KCNH2 (0.44)	KCNH2
	SCHEMBL1379484	0.86	KMT2A (0.53)	MEN1KMT2APOLB
	SCHEMBL1375407	0.81	KCNH2 (0.46)	KCNH2
	SCHEMBL2920022	0.79	KCNH2 (0.43)	KCNH2
	SCHEMBL2924413	0.78	KCNH2 (0.43)	KCNH2
	SCHEMBL2923848	0.76	ROCK1 (0.35)	KCNH2
	SCHEMBL2925502	0.75	KCNH2 (0.57)	KCNH2
	SCHEMBL14372267	0.73	KCNH2 (0.43)	KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.